Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: Preparation, in vitro and in vivo evaluation
- 1 July 2014
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 469 (1), 23-30
- https://doi.org/10.1016/j.ijpharm.2014.04.044
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Injectable implants for the sustained release of protein and peptide drugsDrug Discovery Today, 2013
- In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymerJournal of Controlled Release, 2012
- Injectable PLA-basedin situforming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterizationDrug Development and Industrial Pharmacy, 2012
- Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behaviorJournal of Pharmaceutical Sciences, 2009
- Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery systemInternational Journal of Pharmaceutics, 2007
- The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectablein situ forming PLGA implantPolymers for Advanced Technologies, 2006
- Controlled delivery of testosterone from smart polymer solution based systems: In vitro evaluationInternational Journal of Pharmaceutics, 2005
- Sustained release of human growth hormone from PLGA solution depots.Pharmaceutical Research, 1999
- Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymersBiomaterials, 1996